Literature DB >> 23411422

Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray.

Ying-Xin Wang1, Xiao-Yan Zhang, Bao-Feng Zhang, Chang-Qing Yang, Heng-Jun Gao.   

Abstract

BACKGROUND: To study the expression levels and clinical significance of Argonaute2 (EIF2C2) on colonic carcinomas and normal tissues.
METHODS: Colon tissue samples from 90 cases of colonic carcinomas and 90 normal subjects were accumulated and made into a tissue microarray containing 360 dots. Expression of Argonaute2 (EIF2C2) was detected by immunohistochemical staining of the tissue microarray.
RESULTS: There was significant difference in the expression levels of Argonaute2 (EIF2C2) between colonic carcinomas and normal tissues (P<0.01). However, the expression of Argonaute2 (EIF2C2) was not related to sex, age, position, differentiation, lymphatic metastasis and clinical stage of the tumor (P>0.05).
CONCLUSION: Abnormal expression of Argonaute2 (EIF2C2) may be correlated with colon tumorigenesis.

Entities:  

Keywords:  Argonaute2; Tissue mircroarray; colonic carcinoma; immunohistochemstry

Mesh:

Substances:

Year:  2013        PMID: 23411422      PMCID: PMC3563199     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  46 in total

1.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

2.  TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.

Authors:  Thimmaiah P Chendrimada; Richard I Gregory; Easwari Kumaraswamy; Jessica Norman; Neil Cooch; Kazuko Nishikura; Ramin Shiekhattar
Journal:  Nature       Date:  2005-06-22       Impact factor: 49.962

Review 3.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 4.  microRNAs as oncogenes and tumor suppressors.

Authors:  Baohong Zhang; Xiaoping Pan; George P Cobb; Todd A Anderson
Journal:  Dev Biol       Date:  2006-08-16       Impact factor: 3.582

5.  Overexpression of Dicer in precursor lesions of lung adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Jianhua Luo; Geeta Mantha; Robert W Sobol; Sanja Dacic
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

Review 6.  MicroRNA and cancer: Current status and prospective.

Authors:  Wei Wu; Miao Sun; Gang-Ming Zou; Jianjun Chen
Journal:  Int J Cancer       Date:  2007-03-01       Impact factor: 7.396

7.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Marie Acquafondata; Teresa McHale; Robert W Sobol; Rajiv Dhir
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

Authors:  B Muralidhar; L D Goldstein; G Ng; D M Winder; R D Palmer; E L Gooding; N L Barbosa-Morais; G Mukherjee; N P Thorne; I Roberts; M R Pett; N Coleman
Journal:  J Pathol       Date:  2007-08       Impact factor: 7.996

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  An mRNA m7G cap binding-like motif within human Ago2 represses translation.

Authors:  Marianthi Kiriakidou; Grace S Tan; Styliani Lamprinaki; Mariangels De Planell-Saguer; Peter T Nelson; Zissimos Mourelatos
Journal:  Cell       Date:  2007-05-24       Impact factor: 41.582

View more
  6 in total

1.  EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma.

Authors:  Zhe Zhang; Guojun Zhang; Chuize Kong; Jianbin Bi; Daxin Gong; Xiuyue Yu; Du Shi; Bo Zhan; Peng Ye
Journal:  Tumour Biol       Date:  2015-02-06

2.  Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.

Authors:  Wei Li; Min Liu; Yuan Feng; Yun-Fei Xu; Jian-Ping Che; Guang-Chun Wang; Jun-Hua Zheng; Heng-Jun Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

3.  HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.

Authors:  Yong Liu; Jie Zhou; Cuiwei Zhang; Wenguang Fu; Xiuli Xiao; Sibei Ruan; Yuan Zhang; Xia Luo; Mingxi Tang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

4.  Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer.

Authors:  Rongwei Guan; Lei Peng; Dong Wang; Hongjie He; Dexu Wang; Rui Zhang; Hui Wang; Huiting Hao; Jian Zhang; He Song; Shuning Sui; Xiangning Meng; Xiaobo Cui; Jing Bai; Wenjing Sun; Songbin Fu; Jingcui Yu
Journal:  Oncotarget       Date:  2017-09-08

5.  MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.

Authors:  Petra Vychytilova-Faltejskova; Alena Svobodova Kovarikova; Tomas Grolich; Vladimir Prochazka; Katerina Slaba; Tana Machackova; Jana Halamkova; Marek Svoboda; Zdenek Kala; Igor Kiss; Ondrej Slaby
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

6.  An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells.

Authors:  Jie Li; Jie Dong; Shaohua Li; Wei Xia; Xueting Su; Xingliang Qin; Ying Chen; Hongmei Ding; Hui Li; Aixue Huang; Chenjun Bai; Tongnan Hu; Chenglong Wang; Bingfeng Chu; Ningsheng Shao
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.